Table 1

Demographic data, achromatic contrast sensitivity (ACS), and colour discrimination thresholds for patients with CMVR, HIV, and normal controls

Patient groups
CMVRHIV+Controls
Demographics:
 Number 111629
 Age42.7  (5.5)41.1  (4.5)42.9  (8.3)
 VA/logMAR 0.09 (0.22)0.01 (0.07)−0.02 (0.1)
Achromatic:
 0.33 cpd1.43 (0.23)1.58 (0.21)1.53 (0.13)
 0.66 cpd1.75 (0.28)1.91 (0.20)1.87 (0.10)
 2.2 cpd2.12 (0.53)* 2.43 (0.11)2.41 (0.19)
 3.3 cpd1.99 (0.58)† 2.43 (0.15)2.38 (0.15)
 10 cpd1.43 (0.62)** 1.91 (0.28)1.82 (0.24)
 17 cpd1.06 (0.53)1.37 (0.37)1.30 (0.28)
Chromatic:
 RGDT0.73 (0.49)** 0.42 (0.19)0.42 (0.16)
 TDT0.90 (0.45)‡ 0.42 (0.16)0.40 (0.15)

  • ACS was reduced significantly in patient with CMVR, at 2.2 (*p<0.05), 3.3 (†p<0.005), and 10 cpd (**p<0.01) compared with controls and patients with HIV infection. Chromatic discrimination threshold was reduced on the red-green (**p<0.01) and the tritan axes (‡p<0.0001).